Shares of Nordson Corporation (NDSN) surged 5.49% in after-hours trading on Wednesday, following the release of the company's fiscal second-quarter 2025 results that exceeded analyst expectations. The dispensing equipment maker reported robust financial performance and provided an optimistic outlook, driving investor enthusiasm.
Nordson announced adjusted earnings per share of $2.42 for the quarter ended April 30, surpassing the analyst consensus estimate of $2.36. This represents a 3.42% increase from $2.34 per share in the same period last year. The company's quarterly sales reached $682.94 million, up 4.96% year-over-year and beating the analyst estimate of $674.04 million.
The strong performance was attributed to several factors, including an 8% favorable acquisition impact, which helped offset a 2% organic sales decrease. Nordson's medical and fluid solutions business, bolstered by the acquisition of Atrion in May 2024, saw a significant 20% sales growth to $203 million. The company also reported a 5% growth in backlog during the quarter, indicating potential for future revenue growth. Looking ahead, Nordson provided an optimistic third-quarter outlook, forecasting adjusted earnings per share between $2.55 and $2.75, and sales between $710 million and $750 million, both ranges surpassing current analyst expectations.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.